Garcia-Vallejo JJ - Search Results

1

The physiological role of DC-SIGN: a tale of mice and men.

Garcia-Vallejo JJ, van Kooyk Y. Garcia-Vallejo JJ, et al. Trends Immunol. 2013 Oct;34(10):482-6. doi: 10.1016/j.it.2013.03.001. Epub 2013 Apr 20. Trends Immunol. 2013. PMID: 23608151 Review.

2

DC-SIGN mediates adhesion and rolling of dendritic cells on primary human umbilical vein endothelial cells through LewisY antigen expressed on ICAM-2.

García-Vallejo JJ, van Liempt E, da Costa Martins P, Beckers C, van het Hof B, Gringhuis SI, Zwaginga JJ, van Dijk W, Geijtenbeek TB, van Kooyk Y, van Die I. García-Vallejo JJ, et al. Mol Immunol. 2008 Apr;45(8):2359-69. doi: 10.1016/j.molimm.2007.11.001. Epub 2007 Dec 26. Mol Immunol. 2008. PMID: 18155766

3

Dendritic cells and C-type lectin receptors: coupling innate to adaptive immune responses.

van Vliet SJ, García-Vallejo JJ, van Kooyk Y. van Vliet SJ, et al. Immunol Cell Biol. 2008 Oct;86(7):580-7. doi: 10.1038/icb.2008.55. Epub 2008 Aug 5. Immunol Cell Biol. 2008. PMID: 18679407 Review.

4

Endogenous ligands for C-type lectin receptors: the true regulators of immune homeostasis.

García-Vallejo JJ, van Kooyk Y. García-Vallejo JJ, et al. Immunol Rev. 2009 Jul;230(1):22-37. doi: 10.1111/j.1600-065X.2009.00786.x. Immunol Rev. 2009. PMID: 19594627 Review.

5

Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.

Singh SK, Stephani J, Schaefer M, Kalay H, García-Vallejo JJ, den Haan J, Saeland E, Sparwasser T, van Kooyk Y. Singh SK, et al. Mol Immunol. 2009 Dec;47(2-3):164-74. doi: 10.1016/j.molimm.2009.09.026. Epub 2009 Oct 8. Mol Immunol. 2009. PMID: 19818504

6

Multivalent glycopeptide dendrimers for the targeted delivery of antigens to dendritic cells.

García-Vallejo JJ, Ambrosini M, Overbeek A, van Riel WE, Bloem K, Unger WW, Chiodo F, Bolscher JG, Nazmi K, Kalay H, van Kooyk Y. García-Vallejo JJ, et al. Mol Immunol. 2013 Apr;53(4):387-97. doi: 10.1016/j.molimm.2012.09.012. Epub 2012 Oct 24. Mol Immunol. 2013. PMID: 23103377

7

Glycan-based DC-SIGN targeting vaccines to enhance antigen cross-presentation.

van Kooyk Y, Unger WW, Fehres CM, Kalay H, García-Vallejo JJ. van Kooyk Y, et al. Mol Immunol. 2013 Sep;55(2):143-5. doi: 10.1016/j.molimm.2012.10.031. Epub 2012 Nov 14. Mol Immunol. 2013. PMID: 23158834 Review.

8

Glycodendrimers prevent HIV transmission via DC-SIGN on dendritic cells.

Garcia-Vallejo JJ, Koning N, Ambrosini M, Kalay H, Vuist I, Sarrami-Forooshani R, Geijtenbeek TB, van Kooyk Y. Garcia-Vallejo JJ, et al. Int Immunol. 2013 Apr;25(4):221-33. doi: 10.1093/intimm/dxs115. Epub 2013 Jan 4. Int Immunol. 2013. PMID: 23291968

9

Glycan-based DC-SIGN targeting to enhance antigen cross-presentation in anticancer vaccines.

García-Vallejo JJ, Unger WW, Kalay H, van Kooyk Y. García-Vallejo JJ, et al. Oncoimmunology. 2013 Feb 1;2(2):e23040. doi: 10.4161/onci.23040. Oncoimmunology. 2013. PMID: 23525136 Free PMC article.

10

Interaction of the Capsular Polysaccharide A from Bacteroides fragilis with DC-SIGN on Human Dendritic Cells is Necessary for Its Processing and Presentation to T Cells.

Bloem K, García-Vallejo JJ, Vuist IM, Cobb BA, van Vliet SJ, van Kooyk Y. Bloem K, et al. Front Immunol. 2013 May 6;4:103. doi: 10.3389/fimmu.2013.00103. eCollection 2013. Front Immunol. 2013. PMID: 23653626 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

125 results

Search Page